henhaobio
Sign in

Matrix BiologyGenomicsPeer-reviewed journal article

Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes

Mateusz S. WietechaiD, David Lauenstein, Michael CangkramaiD, Sybille SeileriD, Juyoung JiniD, Andreas GoppeltiD, Manfred ClaasseniD, Mitchell Paul LevesqueiD, Reinhard DummeriD, Sabine WerneriD

PDFDOIPreprint

Abstract

Healing wounds and cancers present remarkable cellular and molecular parallels, but the specific roles of the healing phases are largely unknown. We developed a bioinformatics pipeline to identify genes and pathways that define distinct phases across the time course of healing. Their comparison to cancer transcriptomes revealed that a resolution-phase wound signature is associated with increased severity in skin cancer and enriches for extracellular matrix-related pathways. Comparisons of transcriptomes of early- and late-phase wound fibroblasts vs skin cancer-associated fibroblasts (CAFs) identified an "early-wound" CAF subtype, which localizes to the inner tumor stroma and expresses collagen-related genes that are controlled by the RUNX2 transcription factor. A "late-wound" CAF subtype localizes to the outer tumor stroma and expresses elastin-related genes. Matrix imaging of primary melanoma tissue microarrays validated these matrix signatures and identified collagen- vs elastin-rich niches within the tumor microenvironment, whose spatial organization predicts survival and recurrence. These results identify wound-regulated genes and matrix patterns with prognostic potential in skin cancer.

Citations
19
FWCI
2.08
Field percentile
top 13%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISForsthuber '23Aschenbrenn '26Friedman '20Hussain '19Delgado '22Mandzhieva '26
71% semantic matchCancer Biology
A. Forsthuber, B. Aschenbrenner, A. Korosec+23 more·bioRxiv·May 3, 2023